ORSOBIO
Live / Applied — Fourth extension granted (statement of use) (as of 02 Feb 2026)
What this means for you
Not registered yet, but its 31 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97656065
- Mark type
- Stylized text
- Filed
- 31 Oct 2022
- Published for opposition
- 12 Dec 2023
- Attorney of record
- Connie Ellerbach
Goods and services
- Class 042 — Scientific and technological services: Development of drugs targeting the metabolic system; Development of therapies for the prevention and treatment of metabolic disorders and diseases that affect the heart, liver, kidney and other organs; Development of pharmaceuticals for the prevention and treatment of metabolic disorders and diseases that affect the heart, liver, kidney and other organs; Pharmaceutical drug discovery and development services
Owner
- ORSOBIO, INC., Menlo Park, CA, US
- ORSOBIO, INC., Menlo Park, CA, US
Prosecution history
- 10 Sept 2026 — DIVISIONAL PROCESSING COMPLETE
- 03 Aug 2026 — DIVISIONAL REQUEST RECEIVED
- 09 Sept 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 03 Aug 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 31 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2026 — SOU EXTENSION 4 GRANTED
- 02 Feb 2026 — SOU EXTENSION 4 FILED
- 02 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2025 — SOU EXTENSION 3 GRANTED
- 05 Aug 2025 — SOU EXTENSION 3 FILED
- 05 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED